148 related articles for article (PubMed ID: 29547432)
1. The Food and Drug Administration Should Mandate Risk Evaluation and Mitigation Strategies Training for All Opioids.
Soelberg CD; Chou R; Ramachandran BK; Berkeley A; Brown RE
Anesth Analg; 2018 Apr; 126(4):1413-1417. PubMed ID: 29547432
[No Abstract] [Full Text] [Related]
2. Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).
Nelson LS; Perrone J
JAMA; 2012 Aug; 308(5):457-8. PubMed ID: 22851109
[No Abstract] [Full Text] [Related]
3. The US Opioid Crisis: Current Federal and State Legal Issues.
Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
[TBL] [Abstract][Full Text] [Related]
4. Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic.
Gottlieb S; Woodcock J
JAMA; 2017 Aug; 318(5):421-422. PubMed ID: 28687816
[No Abstract] [Full Text] [Related]
5. Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine.
Bonnie RJ; Kesselheim AS; Clark DJ
JAMA; 2017 Aug; 318(5):423-424. PubMed ID: 28715551
[No Abstract] [Full Text] [Related]
6. Forecasting the opioid epidemic.
Burke DS
Science; 2016 Nov; 354(6312):529. PubMed ID: 27811241
[No Abstract] [Full Text] [Related]
7. REMS; red tape, or a remedy for opioid abuse?
Porada S
J Fam Pract; 2011 Sep; 60(9 Suppl):S55-62. PubMed ID: 22442761
[No Abstract] [Full Text] [Related]
8. The Food and Drug Administration opioid Risk Evaluation and Mitigation Strategy.
Lipman AG
J Pain Palliat Care Pharmacother; 2009; 23(3):219-21. PubMed ID: 19670017
[No Abstract] [Full Text] [Related]
9. The opioid crisis: the needle and the damage done.
The Lancet Gastroenterology Hepatology
Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):385. PubMed ID: 28497746
[No Abstract] [Full Text] [Related]
10. Transgender Patients, Isotretinoin, and US Food and Drug Administration-Mandated Risk Evaluation and Mitigation Strategies: A Prescription for Inclusion.
Katz KA
JAMA Dermatol; 2016 May; 152(5):513-4. PubMed ID: 26762226
[No Abstract] [Full Text] [Related]
11. Opioid risk management: understanding FDA mandated risk evaluation and mitigation strategies (REMS).
Sloan PA
J Opioid Manag; 2009; 5(3):131-3. PubMed ID: 19662921
[No Abstract] [Full Text] [Related]
12. Access to opioids: a balance of harms.
The Lancet Oncology
Lancet Oncol; 2017 Oct; 18(10):1285. PubMed ID: 28971809
[No Abstract] [Full Text] [Related]
13. The American Opioid Epidemic: Population Health Implications and Potential Solutions. Report from the National Stakeholder Panel.
Clarke JL; Skoufalos A; Scranton R
Popul Health Manag; 2016 Mar; 19 Suppl 1():S1-10. PubMed ID: 26908092
[No Abstract] [Full Text] [Related]
14. Coupling Policymaking with Evaluation - The Case of the Opioid Crisis.
Barnett ML; Gray J; Zink A; Jena AB
N Engl J Med; 2017 Dec; 377(24):2306-2309. PubMed ID: 29236636
[No Abstract] [Full Text] [Related]
15. FDA remodels REMS for opioid medications.
Stone A
ONS Connect; 2012 Sep; 27(9):18. PubMed ID: 23008909
[No Abstract] [Full Text] [Related]
16. Reducing the Community-Prescribed Opioid Load: A Public Health Approach to the Opioid Epidemic.
Lew J; Moore K
J Opioid Manag; 2016; 12(4):235-7. PubMed ID: 27575823
[No Abstract] [Full Text] [Related]
17. Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy.
Bucher Bartelson B; Le Lait MC; Green JL; Cepeda MS; Coplan PM; Maziere JY; Wedin GP; Dart RC
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1061-1070. PubMed ID: 28758289
[TBL] [Abstract][Full Text] [Related]
18. Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume.
Divino V; Cepeda MS; Coplan P; Maziere JY; Yuan Y; Wade RL
J Opioid Manag; 2017; 13(3):157-168. PubMed ID: 28829517
[TBL] [Abstract][Full Text] [Related]
19. ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes.
Cepeda MS; Coplan PM; Kopper NW; Maziere JY; Wedin GP; Wallace LE
Pain Med; 2017 Jan; 18(1):78-85. PubMed ID: 27373304
[TBL] [Abstract][Full Text] [Related]
20. A public health outbreak management framework applied to surges in opioid overdoses.
Moore K; Boulet M; Lew J; Papadomanolakis-Pakis N
J Opioid Manag; 2017; 13(5):273-281. PubMed ID: 29199393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
